Skip to main content

Table 1 Demographic and clinical characteristics of subjects eligible for inclusion

From: The effect of long-term homocysteine-lowering on carotid intima-media thickness and flow-mediated vasodilation in stroke patients: a randomized controlled trial and meta-analysis

 

Participants (n = 173)

Non-participants (n = 170)

p-value

Age at event (years)

65 ± 11

64 ± 14

0.58

Sex (male)

126 (73)

96 (56)

< 0.01

Stroke type

   

Ischemic

124 (72)

117 (69)

0.33

TIA

34 (20)

28 (16)

 

Haemorrhagic

13 (7)

22 (13)

 

Unknown

2 (1)

3 (2)

 

Medications

   

Antiplatelet agent

140 (81)

131 (77)

0.40

Warfarin

28 (16)

30 (18)

0.76

Statin

57 (33)

51 (30)

0.54

Antihypertensive agent

97 (56)

83 (49)

0.20

Risk factors

   

Hypertension*

120 (69)

105 (62)

0.14

Hypercholesterolemia†

61 (35)

50 (30)

0.31

Diabetes‡

29 (17)

32 (19)

0.71

Current smoker

33 (19)

31 (18)

0.84

Clinical characteristics

   

Systolic BP (mmHg)

133 ± 18

134 ± 18

0.75

Diastolic BP (mmHg)

78 ± 10

78 ± 10

0.78

GFR (ml/min/1.73 m2)§

87 ± 21

90 ± 27

0.35

  1. Values are mean ± standard deviation or number (%)
  2. P-values for continuous variables are from a two-sample t-test, from a normal approximation to the binomial for proportions and from a chi-square test for categories.
  3. TIA indicates transient ischemic attack of eye or brain; BMI, body mass index; BP, blood pressure, GFR, glomerular filtration rate.
  4. *History of previous or current hypertension
  5. †Treated for hypercholesterolaemia
  6. ‡ Includes type I, type II and impaired fasting glycaemia
  7. §Estimated using the Modification of Diet in Renal Disease Study equation [32]
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us